The rare mutation that lets high-risk brains dodge Alzheimer's
Scientists found a natural defense against protein buildup, opening a new path to preventive treatments.

Loading the Newsroom
Curating from trusted global sources…
28 briefings · “some”
Scientists found a natural defense against protein buildup, opening a new path to preventive treatments.
The former president's intervention raises the stakes in a federal probe into immigration paperwork that has put a prominent progressive lawmaker in the crosshairs.
A portable, electricity-free diagnostic could transform emergency care in ambulances, disaster zones, and remote clinics where lab machines are out of reach.
Solana's Pudong office and ad campaign signal a possible crypto window in China.
New satellite data on 100-meter ice cliffs slashes the worst-case sea-level tail risk, yet Thwaites still holds a deep-bed hazard.
The AI lab is touting growth to investors even as the industry's infrastructure bill sparks fresh unease. Here's what the debut signals for the capex supercycle.
Epic rebuilt its Games Launcher from scratch with AI, betting speed can dent Valve's grip - and it warns users to expect bugs.
A new research-level math benchmark called First Proof shows frontier AI models excelling while open-source rivals struggle, raising cost and access questions for builders.
The Dutch chip-equipment giant's forward order interest signals AI-driven demand for advanced lithography is built to last well past this cycle.
Graduates are using AI to misrepresent themselves across hundreds of applications, and the research says the strategy is backfiring. Here is what it means for hiring managers and job seekers.
Analysts are slashing earnings forecasts as the twin measures collide with a domestic sales slump, pushing 50-odd EV makers toward a do-or-die moment.
The Dutch chip-equipment giant just told investors its supply plans fall short for two straight years, and customers are already booking for 2030.